Invesco
ACHV icon

Invesco’s Achieve Life Sciences ACHV Stock Holding History

Invesco’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-73,644
Closed -$197K – 3759
2025
Q1 		$197K Buy
73,644
+56,856
+339% +$177K ﹤0.01% 3513
2024
Q4 		$59.1K Buy
16,788
+715
+4% +$3.24K ﹤0.01% 3677
2024
Q3 		$76.2K Sell
16,073
-141
-0.9% -$644 ﹤0.01% 3650
2024
Q2 		$76.2K Buy
+16,214
New +$78.1K ﹤0.01% 3783

Other funds holding ACHV

PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Invesco's ACHV Position: Q2 2025 in Review

Invesco sold out of Achieve Life Sciences (ACHV) in Q2 2025, closing a stake of 73,644 shares — an estimated $197K sold.

Invesco first reported a position in ACHV in Q2 2024 and held it in 4 quarters. The position peaked at $197K in Q1 2025. 65 funds tracked by Wall St. Rank hold ACHV as of Q2 2025.

  • Invesco reported no remaining Achieve Life Sciences position as of Q2 2025 after selling out during the quarter.
  • Invesco sold 73,644 Achieve Life Sciences shares in Q2 2025, an estimated $197K.
  • Invesco first reported a position in Achieve Life Sciences in Q2 2024 and held it in 4 quarters.
  • Invesco's Achieve Life Sciences position peaked at $197K in Q1 2025.
  • 65 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2025.

Based on Invesco's 13F filing for Q2 2025, filed 13 Aug 2025.